annual CFO:
-$225.97M-$59.66M(-35.88%)Summary
- As of today (June 28, 2025), CRNX annual cash flow from operations is -$225.97 million, with the most recent change of -$59.66 million (-35.88%) on December 31, 2024.
- During the last 3 years, CRNX annual CFO has fallen by -$137.38 million (-155.08%).
- CRNX annual CFO is now -4032.59% below its all-time high of -$5.47 million, reached on December 31, 2016.
Performance
CRNX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$88.45M-$23.78M(-36.77%)Summary
- As of today (June 28, 2025), CRNX quarterly cash flow from operations is -$88.45 million, with the most recent change of -$23.78 million (-36.77%) on March 31, 2025.
- Over the past year, CRNX quarterly CFO has dropped by -$35.60 million (-67.35%).
- CRNX quarterly CFO is now -3922.37% below its all-time high of -$2.20 million, reached on June 30, 2017.
Performance
CRNX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$261.57M-$35.60M(-15.75%)Summary
- As of today (June 28, 2025), CRNX TTM cash flow from operations is -$261.57 million, with the most recent change of -$35.60 million (-15.75%) on March 31, 2025.
- Over the past year, CRNX TTM CFO has dropped by -$83.12 million (-46.58%).
- CRNX TTM CFO is now -11145.31% below its all-time high of -$2.33 million, reached on March 31, 2017.
Performance
CRNX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CRNX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.9% | -67.3% | -46.6% |
| 3 y3 years | -155.1% | -553.1% | -218.7% |
| 5 y5 years | -387.2% | -623.2% | -404.4% |
CRNX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -155.1% | at low | -553.1% | at low | -218.7% | at low |
| 5 y | 5-year | -387.2% | at low | -623.2% | at low | -404.4% | at low |
| alltime | all time | -4032.6% | at low | -3922.4% | at low | <-9999.0% | at low |
CRNX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$88.45M(+36.8%) | -$261.57M(+15.8%) |
| Dec 2024 | -$225.97M(+35.9%) | -$64.67M(+2.9%) | -$225.97M(+13.1%) |
| Sep 2024 | - | -$62.82M(+37.7%) | -$199.81M(+12.0%) |
| Jun 2024 | - | -$45.62M(-13.7%) | -$178.33M(-0.1%) |
| Mar 2024 | - | -$52.86M(+37.2%) | -$178.44M(+7.3%) |
| Dec 2023 | -$166.31M(+44.4%) | -$38.52M(-6.8%) | -$166.31M(+2.0%) |
| Sep 2023 | - | -$41.34M(-9.6%) | -$163.00M(+1.8%) |
| Jun 2023 | - | -$45.73M(+12.3%) | -$160.14M(+12.5%) |
| Mar 2023 | - | -$40.72M(+15.7%) | -$142.38M(+23.6%) |
| Dec 2022 | -$115.20M(+30.0%) | -$35.21M(-8.5%) | -$115.20M(+12.0%) |
| Sep 2022 | - | -$38.48M(+37.5%) | -$102.90M(+14.2%) |
| Jun 2022 | - | -$27.98M(+106.6%) | -$90.09M(+9.8%) |
| Mar 2022 | - | -$13.54M(-40.9%) | -$82.06M(-7.4%) |
| Dec 2021 | -$88.59M(+42.8%) | -$22.90M(-10.8%) | -$88.59M(+8.5%) |
| Sep 2021 | - | -$25.67M(+28.7%) | -$81.63M(+10.4%) |
| Jun 2021 | - | -$19.95M(-0.6%) | -$73.96M(+5.9%) |
| Mar 2021 | - | -$20.07M(+25.9%) | -$69.86M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$62.03M(+33.7%) | -$15.94M(-11.5%) | -$62.03M(+4.2%) |
| Sep 2020 | - | -$18.00M(+13.6%) | -$59.54M(+8.0%) |
| Jun 2020 | - | -$15.86M(+29.6%) | -$55.14M(+6.3%) |
| Mar 2020 | - | -$12.23M(-9.1%) | -$51.85M(+11.8%) |
| Dec 2019 | -$46.38M(+138.4%) | -$13.45M(-1.2%) | -$46.38M(+19.1%) |
| Sep 2019 | - | -$13.61M(+8.3%) | -$38.94M(+25.5%) |
| Jun 2019 | - | -$12.57M(+85.9%) | -$31.03M(+36.0%) |
| Mar 2019 | - | -$6.76M(+12.5%) | -$22.81M(+17.2%) |
| Dec 2018 | -$19.46M(+105.3%) | -$6.01M(+5.6%) | -$19.46M(+21.9%) |
| Sep 2018 | - | -$5.69M(+30.9%) | -$15.96M(+25.6%) |
| Jun 2018 | - | -$4.35M(+27.7%) | -$12.71M(+20.4%) |
| Mar 2018 | - | -$3.41M(+35.7%) | -$10.56M(+11.4%) |
| Dec 2017 | -$9.48M(+73.4%) | -$2.51M(+2.8%) | -$9.48M(+36.0%) |
| Sep 2017 | - | -$2.44M(+11.1%) | -$6.97M(+54.0%) |
| Jun 2017 | - | -$2.20M(-5.5%) | -$4.53M(+94.5%) |
| Mar 2017 | - | -$2.33M | -$2.33M |
| Dec 2016 | -$5.47M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual CFO year-on-year change?
- What is Crinetics Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly CFO year-on-year change?
- What is Crinetics Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM CFO year-on-year change?
What is Crinetics Pharmaceuticals annual cash flow from operations?
The current annual CFO of CRNX is -$225.97M
What is the all time high annual CFO for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual cash flow from operations is -$5.47M
What is Crinetics Pharmaceuticals annual CFO year-on-year change?
Over the past year, CRNX annual cash flow from operations has changed by -$59.66M (-35.88%)
What is Crinetics Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CRNX is -$88.45M
What is the all time high quarterly CFO for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly cash flow from operations is -$2.20M
What is Crinetics Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CRNX quarterly cash flow from operations has changed by -$35.60M (-67.35%)
What is Crinetics Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CRNX is -$261.57M
What is the all time high TTM CFO for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM cash flow from operations is -$2.33M
What is Crinetics Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CRNX TTM cash flow from operations has changed by -$83.12M (-46.58%)